(Q33524781)

27 July 2017

title

Correlation of telomere length shortening with promoter methylation profile of p16/Rb and p53/p21 pathways in breast cancer (English)

1 reference

27 July 2017

0 references

Ramin Radpour

1

0 references

Wolfgang Holzgreve

7

object named as

Wolfgang Holzgreve

1 reference

27 July 2017

8

Xiao Yan Zhong

1 reference

27 July 2017

4

Corina Kohler

1 reference

27 July 2017

Zeinab Barekati

2

1 reference

27 July 2017

Mahdi Montazer Haghighi

3

1 reference

27 July 2017

Reza Asadollahi

5

1 reference

27 July 2017

Peyman Mohammadi Torbati

6

1 reference

27 July 2017

publication date

15 January 2010

1 reference

27 July 2017

1 reference

27 July 2017

volume

23

1 reference

27 July 2017

issue

5

1 reference

27 July 2017

page(s)

763-772

1 reference

Structure and function of telomeres

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Telomere loss: mitotic clock or genetic time bomb?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Role of Telomeres and Telomerase in the Pathogenesis of Human Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Telomerase and cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

The signals and pathways activating cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Significant Role for p16INK4a in p53-Independent Telomere-Directed Senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Telomere measurement by quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Cytosine methylation profiling of cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

High-throughput hacking of the methylation patterns in breast cancer by in vitro transcription and thymidine-specific cleavage mass array on MALDI-TOF silico-chip

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Simultaneous isolation of DNA, RNA, and proteins for genetic, epigenetic, transcriptomic, and proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Effect of fixatives and tissue processing on the content and integrity of nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Assessment of telomere length and factors that contribute to its stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

The telomere length dynamic and methods of its assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Telomeres: beginning to understand the end.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Breast cancer survival is associated with telomere length in peripheral blood cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Telomeres: prognostic markers for solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Telomere DNA content predicts breast cancer-free survival interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Tumor-specific changes in mtDNA content in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Telomeres and human disease: ageing, cancer and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Clinical implications and utility of field cancerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.195

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/MODPATHOL.2009.195

1 reference

Dimensions Publication ID

27 July 2017

1037848977

0 references

1 reference